These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


578 related items for PubMed ID: 17293168

  • 21. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
    Xin HY, Jiang DJ, Jia SJ, Song K, Wang GP, Li YJ, Chen FP.
    Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
    [Abstract] [Full Text] [Related]

  • 22. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S, Laguna-Fernández A, Lázaro-Franco M, Sobrino A, Bueno-Betí C, Tarín JJ, Monsalve E, Sanchís J, Hermenegildo C.
    Mol Cell Endocrinol; 2013 Jan 05; 365(1):11-6. PubMed ID: 22982060
    [Abstract] [Full Text] [Related]

  • 23. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.
    Lu CW, Lin Y, Lei YP, Wang L, He ZM, Xiong Y.
    PLoS One; 2017 Jan 05; 12(7):e0179908. PubMed ID: 28715444
    [Abstract] [Full Text] [Related]

  • 24. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M, Shichiri M, Imamura M, Azuma H, Hirata Y.
    Hypertension; 2008 Nov 05; 52(5):903-9. PubMed ID: 18824664
    [Abstract] [Full Text] [Related]

  • 25. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
    Xiao HB, Jun-Fang, Lu XY, Chen XJ, Chao-Tan, Sun ZL.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):213-22. PubMed ID: 19549512
    [Abstract] [Full Text] [Related]

  • 26. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway.
    Peng ZY, Zhao SP, He BM, Peng DQ, Hu M.
    Mol Cell Biochem; 2011 May 15; 351(1-2):243-9. PubMed ID: 21264497
    [Abstract] [Full Text] [Related]

  • 27. Protective effect of neferine on endothelial cell nitric oxide production induced by lysophosphatidylcholine: the role of the DDAH-ADMA pathway.
    Peng ZY, Zhang SD, Liu S, He BM.
    Can J Physiol Pharmacol; 2011 Apr 15; 89(4):289-94. PubMed ID: 21526974
    [Abstract] [Full Text] [Related]

  • 28. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX, Xiong XM, Hu CP, Li YJ.
    Clin Exp Pharmacol Physiol; 2010 May 15; 37(5-6):630-5. PubMed ID: 20132235
    [Abstract] [Full Text] [Related]

  • 29. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
    Wang D, Gill PS, Chabrashvili T, Onozato ML, Raggio J, Mendonca M, Dennehy K, Li M, Modlinger P, Leiper J, Vallance P, Adler O, Leone A, Tojo A, Welch WJ, Wilcox CS.
    Circ Res; 2007 Sep 14; 101(6):627-35. PubMed ID: 17673667
    [Abstract] [Full Text] [Related]

  • 30. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
    Lin Y, Feng M, Lu CW, Lei YP, He ZM, Xiong Y.
    Eur J Pharmacol; 2017 Mar 05; 798():43-48. PubMed ID: 28163022
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH.
    Eid HM, Lyberg T, Arnesen H, Seljeflot I.
    Atherosclerosis; 2007 Oct 05; 194(2):e1-8. PubMed ID: 17141242
    [Abstract] [Full Text] [Related]

  • 36. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Oct 05; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 37. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S, Wakino S, Kanda T, Homma K, Yoshioka K, Hasegawa K, Sugano N, Kimoto M, Saruta T, Hayashi K.
    J Am Soc Nephrol; 2007 Mar 05; 18(3):741-9. PubMed ID: 17267746
    [Abstract] [Full Text] [Related]

  • 38. 17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
    Dai Z, Zhu HQ, Jiang DJ, Jiang JL, Deng HW, Li YJ.
    Int J Cardiol; 2004 Aug 05; 96(2):223-7. PubMed ID: 15262037
    [Abstract] [Full Text] [Related]

  • 39. Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.
    Yang TL, Chen MF, Luo BL, Yu J, Jiang JL, Li YJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug 05; 370(2):79-83. PubMed ID: 15316718
    [Abstract] [Full Text] [Related]

  • 40. Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
    Jiang DJ, Jiang JL, Zhu HQ, Tan GS, Liu SQ, Xu KP, Li YJ.
    J Ethnopharmacol; 2004 Aug 05; 93(2-3):295-306. PubMed ID: 15234768
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.